Castellum, Inc.
New York Stock Exchange AmericanCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Glen R. Ives
- Full Time Employees
- 238
- Sector
- Technology
- Industry
- Information Technology Services
- Address
- 3 Bethesda Metro Center Bethesda MD United States of America 20814
- IPO Date
- Oct 13, 2022
- CIK
- 0001877939
- Website
- castellumus.com
- Similar Companies
- Business
- Castellum, Inc. (NYSE American: CTM) provides cybersecurity, information technology, electronic and information warfare, and information operations services to federal government, financial services, healthcare, and other data-intensive sectors. The company offers intelligence analysis, software development and engineering, program management, strategic and mission planning, information assurance, cybersecurity and policy support, data analytics, and model-based systems engineering (MBSE); it operates primarily in the United States from its headquarters in Vienna, Virginia, where it was founded in 2019. Castellum executes strategic acquisitions to expand its capabilities in these areas and recently reported record revenues of $14.6 million in Q3 2025, up from $14.0 million in Q2 2025, alongside significant debt reduction; in July 2025, its newly formed Castellum Advanced Technology Products, Inc. subsidiary entered a reseller agreement with AmpliTech Group, Inc. (Nasdaq: AMPG) to offer advanced technology products to clients, and in August 2025, it signed another reseller agreement with Tradewinds Networks, Inc. to distribute GuardTower AI products.
Castellum Reminds Stockholders to Submit Their Vote at Its Upcoming 2026 Annual Meeting
Canterra Minerals Completes Winter Drilling and Commences Geophysical Survey at Critical Minerals and Gold Projects in Central Newfoundland
Castellum Announces First Quarter 2026 Financial Results
Castellum, Inc. Achieves CMMC Level 2 C3PAO Certification
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study
Castellum, Inc. Announces 2025 Unaudited Financial Results
Castellum AB (publ) (CWQXY) Q4 2025 Earnings Call Transcript
Castellum, Inc. Pays Off All Debt
Castellum, Inc. Announces the Award of a $49.8 Million Recompete Contract to its SSI Subsidiary
Castellum (NYSEAMERICAN:CTM) General Counsel Jay Wright Sells 30,000 Shares of Stock
Castellum, INC.'s CEO Provides Its Shareholders a Corporate Update
Castellum Announces the Award of Multiple Missile Defense Agency SHIELD IDIQ Contracts
Castellum AB (publ) (CWQXY) Discusses Back to Basics Strategy Focused on Profitability and Portfolio Rotation Transcript
Castellum, Inc. Completes $2 Million Paydown, Retires Note Payable to Robert Eisiminger
Castellum, Inc. Reports Breakthrough Q3 2025 Results with First-Ever Positive Net Income
Castellum, Inc. Announces the Award of a $66.2 million Full and Open Contract to its SSI Subsidiary
Castellum AB (publ) (CWQXY) Q3 2025 Earnings Call Transcript
Castellum, Inc. to Attend the 2025 Maxim Growth Summit
Castellum, Inc.'s Subsidiary Specialty Systems, Inc. Adds IT Services for GSA MAS Contract
Castellum: Record Revenue, Positive EBITDA, And A Cheap Valuation Make It A Buy